TH152843A - - Google Patents

Info

Publication number
TH152843A
TH152843A TH1401003357A TH1401003357A TH152843A TH 152843 A TH152843 A TH 152843A TH 1401003357 A TH1401003357 A TH 1401003357A TH 1401003357 A TH1401003357 A TH 1401003357A TH 152843 A TH152843 A TH 152843A
Authority
TH
Thailand
Prior art keywords
nanoparticles
involves
eminently
regards
mammals
Prior art date
Application number
TH1401003357A
Other languages
English (en)
Thai (th)
Original Assignee
นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ
Filing date
Publication date
Application filed by นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ filed Critical นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ
Publication of TH152843A publication Critical patent/TH152843A/th

Links

TH1401003357A 2012-12-17 TH152843A (enExample)

Publications (1)

Publication Number Publication Date
TH152843A true TH152843A (enExample) 2016-06-07

Family

ID=

Similar Documents

Publication Publication Date Title
HK1203353A1 (en) Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
EP4124624A3 (en) Antibodies against canine pd-1
BR112014001741A2 (pt) metal em pó compacto extrusado
WO2014158811A8 (en) Newcastle disease viruses and uses thereof
BR112015015319A2 (pt) composições de nanopartícula de albumina e paclitaxel
EP4385572A3 (en) Bispecific antibody capable of being combined with immune cells to enhance tumor killing capability, and preparation method therefor and application thereof
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
EP2778259A3 (en) Metal cleaning compositions including a chloro-fluoro-alkene solvent and method thereof
WO2012017324A3 (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
EP3988673A3 (en) Variants of tnfsf15 and dcr3 associated with crohn's disease
FR3009645B1 (fr) Compositions de nanoparticules d'oxydes metalliques transparents, procedes de fabrication de celles-ci et articles comprenant celles-ci
CL2015000311A1 (es) El compuesto trans-clomifeno en forma particulada, con un tamaño medio de particula de menos de 30 micras, y al menos 90% de las particulas tienen un tamaño de menos de 50 micras; formulacion que lo comprende, util para el tratamiento de hipogonadismo secundario o diabetes tipo 2 en un varon o para el tratamiento de la infertilidad y el cancer de mama en una mujer, entre otras enfermedades.
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
MY172040A (en) Synergistic dietary supplement for enhancing physical performance
Fox et al. The use of doppelgangers to promote health and behavior change
JP2012528941A5 (enExample)
WO2017079403A3 (en) Polymeric nanoparticles
WO2015100113A3 (en) Methods and compositions for treating cancer using peptide nucleic acid-based agents
WO2015038925A3 (en) Novel delivery compositions and methods of using same
PL2895192T3 (pl) Kompozycja farmaceutyczna zawierająca stałą nanocząstkę i co najmniej antygen do leczenia przeciwko wewnątrzkomórkowemu czynnikowi patogennemu
FR3002414B1 (fr) Composition rodenticide sous forme de cereales et/ou de graines agglomerees.
WO2012123924A3 (en) Antimicrobial composition including at least one or more aggregation(s) silver particles
BR112012006267A2 (pt) processo para produzir partículas de substrato orgânico ligadas a nanopartículas ferromagnéticas comutáveis, partículas de substrato para diagnóstico, uso de nanopartículas ferromagnéticas comutáveis, e, medicamento para o tratamento de hipertermia no corpo humano ou animal
IN2014DN11097A (enExample)
HK1203379A1 (en) β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF